On the public citation graph
Obesity-Dependent Metabolic Signatures Associated with Nonalcoholic Fatty Liver Disease Progression
0 signed · 264 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/hep.20701openalex-snapshot
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
inferredcites →https://doi.org/10.1002/hep.23229openalex-snapshot
The plasma lipidomic signature of nonalcoholic steatohepatitis†‡
inferredcites →https://doi.org/10.1002/hep.23458openalex-snapshot
Lipidomic Dissection of Nonalcoholic Steatohepatitis: Moving Beyond Foie Gras to Fat Traffic
inferredcites →https://doi.org/10.1002/hep.23594openalex-snapshot
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
inferredcites →https://doi.org/10.1002/hep.23719openalex-snapshot
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/hep.24642openalex-snapshot
Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers?
inferredcites →https://doi.org/10.1002/hep.510290247openalex-snapshot
Three for the Price of One Knockout—A Mouse Model of A Congenital Peroxisomal Disorder, Steatohepatitis, and Hepatocarcinogenesis
inferredcites →https://doi.org/10.1007/978-3-319-32132-5_447-2openalex-snapshot
Obesity and Overweight
inferredcites →https://doi.org/10.1007/s00125-002-0873-yopenalex-snapshot
Adipose tissue as a buffer for daily lipid flux
inferredcites →https://doi.org/10.1007/s00330-010-1905-5openalex-snapshot
The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis
inferredcites →https://doi.org/10.1016/0009-8981(92)90118-aopenalex-snapshot
The measurement of carnitine and acyl-carnitines: Application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation
inferredcites →https://doi.org/10.1016/j.jhep.2011.01.010openalex-snapshot
No need for a large belly to have NASH
inferredcites →https://doi.org/10.1016/j.metabol.2010.03.006openalex-snapshot
Plasma metabolomic profile in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/s0016-5085(99)70506-8openalex-snapshot
Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆
inferredcites →https://doi.org/10.1016/s0021-9258(18)38001-3openalex-snapshot
Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation.
inferredcites →https://doi.org/10.1016/s0022-2275(20)32553-0openalex-snapshot
Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men
inferredcites →https://doi.org/10.1021/cr9900883openalex-snapshot
Analysis of Nonvolatile Lipids by Mass Spectrometry
inferredcites →https://doi.org/10.1021/pr100101popenalex-snapshot
Metabolic Profiling of Plasma in Overweight/Obese and Lean Men using Ultra Performance Liquid Chromatography and Q-TOF Mass Spectrometry (UPLC−Q-TOF MS)
inferredcites →https://doi.org/10.1021/pr1002593openalex-snapshot
Liquid Chromatography−Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1021/pr900499ropenalex-snapshot
Analytical Error Reduction Using Single Point Calibration for Accurate and Precise Metabolomic Phenotyping
inferredcites →https://doi.org/10.1038/nature09968openalex-snapshot
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity
inferredcites →https://doi.org/10.1038/nmeth0211-117openalex-snapshot
Metabolomics: from small molecules to big ideas
inferredcites →https://doi.org/10.1053/gast.2001.23256openalex-snapshot
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
inferredcites →https://doi.org/10.1053/j.gastro.2005.03.084openalex-snapshot
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1053/j.gastro.2010.09.038openalex-snapshot
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
inferredcites →https://doi.org/10.1053/jhep.2003.50325openalex-snapshot
Nash—Hepatic Metabolism and Not Simply the Metabolic Syndrome
inferredcites →https://doi.org/10.1056/nejme1000206openalex-snapshot
Genetic Susceptibility to Hepatic Steatosis
inferredcites →https://doi.org/10.1056/nejmra011775openalex-snapshot
Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1074/jbc.273.25.15639openalex-snapshot
Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase
inferredcites →https://doi.org/10.1093/ajcn/81.1.35openalex-snapshot
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men1–3
inferredcites →https://doi.org/10.1111/j.1440-1746.2006.04640.xopenalex-snapshot
Role of mitochondria in non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/j.1478-3231.2007.01475.xopenalex-snapshot
Sphingolipid signalling and liver diseases
inferredcites →https://doi.org/10.1113/jphysiol.2009.169060openalex-snapshot
Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury
inferredcites →https://doi.org/10.1126/science.1204265openalex-snapshot
Human Fatty Liver Disease: Old Questions and New Insights
inferredcites →https://doi.org/10.1146/annurev.nutr.28.061807.155438openalex-snapshot
Methionine Metabolism and Liver Disease
inferredcites →https://doi.org/10.1172/jci23621openalex-snapshot
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1210/en.2003-0870openalex-snapshot
Minireview: Weapons of Lean Body Mass Destruction: The Role of Ectopic Lipids in the Metabolic Syndrome
inferredcites →https://doi.org/10.1210/jc.2009-1235openalex-snapshot
Fatty Acids, Insulin Resistance, and Protein Metabolism
inferredcites →https://doi.org/10.1301/nr.2007.jun.s57-s63openalex-snapshot
Obesity and Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1309/rtpm1py6ygbl2g2ropenalex-snapshot
Pathology of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1371/journal.pbio.1000623openalex-snapshot
Association of Lipidome Remodeling in the Adipocyte Membrane with Acquired Obesity in Humans
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3219265openalex-extracted
Targeting Hepatic Glutaminase 1 Ameliorates Non-Alcoholic Steatohepatitis by Restoring Disrupted Hepatic Very-Low Density Lipoproteins Triglyceride Assembly
inferred← citeshttps://doi.org/10.1002/9781118924938.ch5openalex-snapshot
Non‐alcoholic fatty liver disease (NAFLD) as cause of cryptogenic cirrhosis
inferred← citeshttps://doi.org/10.1002/edm2.112openalex-snapshot
The metabolic basis of nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1002/hep.26399openalex-snapshot
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis
inferred← citeshttps://doi.org/10.1002/hep.29721openalex-snapshot
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
inferred← citeshttps://doi.org/10.1002/hep.30319openalex-snapshot
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
inferred← citeshttps://doi.org/10.1002/hep.31312openalex-snapshot
Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)
inferred← citeshttps://doi.org/10.1002/hep4.1107openalex-snapshot
Role of aramchol in steatohepatitis and fibrosis in mice
inferred← citeshttps://doi.org/10.1002/hep4.1188openalex-snapshot
Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
inferred← citeshttps://doi.org/10.1002/hep4.1417openalex-snapshot
Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics
inferred← citeshttps://doi.org/10.1002/hsr2.1554openalex-snapshot
Association of nonalcoholic fatty liver disease and carotid media‐intima thickness: A systematic review and a meta‐analysis
inferred← citeshttps://doi.org/10.1002/jex2.140openalex-snapshot
Lipidomics and biodistribution of extracellular vesicles‐secreted by hepatocytes from Zucker lean and fatty rats
inferred← citeshttps://doi.org/10.1002/lipd.12351openalex-snapshot
Structurally‐engineered fatty acid 1024 ( SEFA ‐1024) improves diet‐induced obesity, insulin resistance, and fatty liver disease
inferred← citeshttps://doi.org/10.1002/mnfr.70182openalex-snapshot
Impact of Nutrition on Sphingolipid‐Regulated Physiology: A Review
inferred← citeshttps://doi.org/10.1002/ueg2.12589openalex-snapshot
One‐step non‐invasive diagnosis of metabolic dysfunction‐associated steatohepatitis and fibrosis in high‐risk population
inferred← citeshttps://doi.org/10.1007/978-3-030-11748-1_16openalex-snapshot
Emerging Circulating Biomarkers for The Diagnosis and Assessment of Treatment Responses in Patients with Hepatic Fat Accumulation, Nash and Liver Fibrosis
inferred← citeshttps://doi.org/10.1007/978-981-99-5162-8_11openalex-snapshot
Lipidomic Profiling in Clinical Practice Using LC-MS
inferred← citeshttps://doi.org/10.1007/978-981-99-5162-8_12openalex-snapshot
Bringing Human Serum Lipidomics to the Forefront of Clinical Practice: Two Clinical Diagnosis Success Stories
inferred← citeshttps://doi.org/10.1007/s00109-021-02076-0openalex-snapshot
Endogenous cortisol excess confers a unique lipid signature and metabolic network
inferred← citeshttps://doi.org/10.1007/s00418-021-02018-4openalex-snapshot
Expression of the putative cannabinoid receptor GPR55 is increased in endometrial carcinoma
inferred← citeshttps://doi.org/10.1007/s00535-013-0766-5openalex-snapshot
Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1007/s10815-018-1284-4openalex-snapshot
Sperm lipidic profiles differ significantly between ejaculates resulting in pregnancy or not following intracytoplasmic sperm injection
inferred← citeshttps://doi.org/10.1007/s10815-019-01670-zopenalex-snapshot
The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles
inferred← citeshttps://doi.org/10.1007/s11306-018-1365-5openalex-snapshot
Pharmacometabolomics applied to zonisamide pharmacokinetic parameter prediction
inferred← citeshttps://doi.org/10.1007/s11357-022-00713-1openalex-snapshot
Human centenarian–associated SIRT6 mutants modulate hepatocyte metabolism and collagen deposition in multilineage hepatic 3D spheroids
inferred← citeshttps://doi.org/10.1007/s11695-018-3612-2openalex-snapshot
A Pilot Study of Serum Sphingomyelin Dynamics in Subjects with Severe Obesity and Non-alcoholic Steatohepatitis after Sleeve Gastrectomy
inferred← citeshttps://doi.org/10.1007/s11695-021-05629-xopenalex-snapshot
Behavior of Iron and Ferritin After Bariatric Surgery in Patients With and Without Hepatic Steatosis
inferred← citeshttps://doi.org/10.1007/s11695-024-07071-1openalex-snapshot
Mid-term Effects of Bariatric Surgery on Metabolic Dysfunction-Associated Fatty Liver Disease Remission and Predictive Factors: A Prospective Study with a Focus on Non-invasive Diagnosis
inferred← citeshttps://doi.org/10.1007/s13238-017-0423-5openalex-snapshot
Structural and functional roles of ether lipids
inferred← citeshttps://doi.org/10.1016/b978-1-78242-084-2.00008-3openalex-snapshot
Using metabolomics to identify biomarkers for metabolic diseases
inferred← citeshttps://doi.org/10.1016/j.ajpath.2024.02.005openalex-snapshot
Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion
inferred← citeshttps://doi.org/10.1016/j.amjsurg.2020.11.045openalex-snapshot
The impact of bariatric surgery on nonalcoholic fatty liver disease as measured using non-invasive tests
inferred← citeshttps://doi.org/10.1016/j.bbalip.2016.07.008openalex-snapshot
Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.bbalip.2020.158857openalex-snapshot
Systems biology approaches to study lipidomes in health and disease
inferred← citeshttps://doi.org/10.1016/j.bcp.2019.113677openalex-snapshot
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116157openalex-snapshot
Human recombinant relaxin-2 (serelaxin) regulates the proteome, lipidome, lipid metabolism and inflammatory profile of rat visceral adipose tissue
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116571openalex-snapshot
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.114535openalex-snapshot
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
inferred← citeshttps://doi.org/10.1016/j.biopha.2025.118439openalex-snapshot
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fraction
inferred← citeshttps://doi.org/10.1016/j.bpj.2014.10.063openalex-snapshot
High-Melting Lipid Mixtures and the Origin of Detergent-Resistant Membranes Studied with Temperature-Solubilization Diagrams
inferred← citeshttps://doi.org/10.1016/j.celrep.2017.11.003openalex-snapshot
Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
inferred← citeshttps://doi.org/10.1016/j.cgh.2016.05.046openalex-snapshot
Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2015.08.011openalex-snapshot
Lipids that determine detergent resistance of MDCK cell membrane fractions
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2017.01.002openalex-snapshot
Lipidomic profile of GM95 cell death induced by Clostridium perfringens alpha-toxin
inferred← citeshttps://doi.org/10.1016/j.chemphyslip.2018.09.010openalex-snapshot
The fatty acids of sphingomyelins and ceramides in mammalian tissues and cultured cells: Biophysical and physiological implications
inferred← citeshttps://doi.org/10.1016/j.clnu.2026.106608openalex-snapshot
Lipidomics uncovers metabolic manifestations related to liver steatosis and low-grade systemic inflammation in diet-treated hereditary fructose intolerance patients
inferred← citeshttps://doi.org/10.1016/j.cmet.2020.01.013openalex-snapshot
Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly
inferred← citeshttps://doi.org/10.1016/j.cmpb.2024.108346openalex-snapshot
Genetic algorithms applied to translational strategy in metabolic-dysfunction associated steatohepatitis (MASH). Learning from mouse models
inferred← citeshttps://doi.org/10.1016/j.diabet.2023.101432openalex-snapshot
Concise review of lipidomics in nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.dib.2015.02.008openalex-snapshot
Data in support of enhancing metabolomics research through data mining
inferred← citeshttps://doi.org/10.1016/j.ebiom.2021.103661openalex-snapshot
The Altered Serum Lipidome and its Diagnostic Potential for Non-Alcoholic Fatty Liver (NAFL)-Associated Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejps.2016.10.020openalex-snapshot
Metabolically active extracellular vesicles released from hepatocytes under drug-induced liver-damaging conditions modify serum metabolome and might affect different pathophysiological processes
inferred← citeshttps://doi.org/10.1016/j.fmc.2017.03.001openalex-snapshot
Esteatosis hepática: diagnóstico y seguimiento
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2013.06.005openalex-snapshot
Esteatohepatitis alcohólica y no alcohólica: ¿quiénes son los pacientes y qué podemos hacer por ellos?
inferred← citeshttps://doi.org/10.1016/j.gastrohep.2014.03.005openalex-snapshot
Hígado graso no alcohólico. Documento de posicionamiento de la Societat Catalana de Digestologia
inferred← citeshttps://doi.org/10.1016/j.jacc.2017.05.018openalex-snapshot
Detrimental Effect of Hypercholesterolemia on High-Density Lipoprotein Particle Remodeling in Pigs
inferred← citeshttps://doi.org/10.1016/j.jacl.2018.07.006openalex-snapshot
Differential effects of restrictive and malabsorptive bariatric surgery procedures on the serum lipidome in obese subjects
inferred← citeshttps://doi.org/10.1016/j.jchromb.2026.125006openalex-snapshot
Targeted serum metabolomics reveals novel metabolic associations between fatty acid and kynurenine metabolism in nonalcoholic fatty liver
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.09.023openalex-snapshot
Acid sphingomyelinase-ceramide system in steatohepatitis: A novel target regulating multiple pathways
inferred← citeshttps://doi.org/10.1016/j.jhep.2015.01.005openalex-snapshot
Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?
inferred← citeshttps://doi.org/10.1016/j.jhep.2015.08.037openalex-snapshot
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis
inferred← citeshttps://doi.org/10.1016/j.jhep.2017.11.013openalex-snapshot
Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
inferred← citeshttps://doi.org/10.1016/j.jhepr.2020.100067openalex-snapshot
Limitations of non-invasive tests for assessment of liver fibrosis
inferred← citeshttps://doi.org/10.1016/j.jhepr.2022.100477openalex-snapshot
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.jlr.2026.101150openalex-snapshot
Lipolysis-Driven Communication Between Adipose Tissue and Liver: A Key Axis in Metabolic Regulation
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2016.01.006openalex-snapshot
Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1016/j.jnutbio.2018.05.018openalex-snapshot
Feeding a slowly digestible carbohydrate diet during pregnancy of insulin-resistant rats prevents the excess of adipogenesis in their offspring
inferred← citeshttps://doi.org/10.1016/j.jpha.2023.05.012openalex-snapshot
Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics
inferred← citeshttps://doi.org/10.1016/j.jprot.2015.01.019openalex-snapshot
Enhancing metabolomics research through data mining
inferred← citeshttps://doi.org/10.1016/j.lfs.2024.123226openalex-snapshot
Oleoylethanolamide mitigates cardiometabolic disruption secondary to obesity induced by high-fat diet in mice
inferred← citeshttps://doi.org/10.1016/j.livres.2026.02.001openalex-snapshot
The role of bile acid dynamics in inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.medcle.2016.01.002openalex-snapshot
Non-alcoholic fatty liver disease. Role of primary care physicians
inferred← citeshttps://doi.org/10.1016/j.medcli.2015.04.012openalex-snapshot
Hígado graso no alcohólico. Papel de los médicos de atención primaria
inferred← citeshttps://doi.org/10.1016/j.metabol.2020.154320openalex-snapshot
The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.metabol.2024.156015openalex-snapshot
Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies
inferred← citeshttps://doi.org/10.1016/j.metabol.2024.156063openalex-snapshot
Serum lipidomic signatures in patients with varying histological severity of metabolic-dysfunction associated steatotic liver disease
inferred← citeshttps://doi.org/10.1016/j.neuron.2014.01.037openalex-snapshot
S-adenosylmethionine Levels Regulate the Schwann Cell DNA Methylome
inferred← citeshttps://doi.org/10.1016/j.phrs.2019.04.009openalex-snapshot
Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue
inferred← citeshttps://doi.org/10.1016/j.plipres.2023.101238openalex-snapshot
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2020.137359openalex-snapshot
Metabolomic, functional, and ecologic responses of the common freshwater fungus Neonectria lugdunensis to mine drainage stress
inferred← citeshttps://doi.org/10.1016/j.spinee.2023.06.005openalex-snapshot
Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells
inferred← citeshttps://doi.org/10.1016/j.tvjl.2016.03.020openalex-snapshot
Effects of sphingolipid extracts on the morphological structure and lipid profile in an in vitro model of canine skin
inferred← citeshttps://doi.org/10.1016/j.xcrm.2024.101853openalex-snapshot
Metabolomics at the cutting edge of risk prediction of MASLD
inferred← citeshttps://doi.org/10.1016/s2468-1253(17)30142-5openalex-snapshot
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1021/acs.jafc.2c04900openalex-snapshot
Total Sesquiterpenoids of Loquat Leaves Alleviated High-Fat Diet-Induced Obesity by Targeting Fecal Metabolic Profiling and Gut Microbiota Composition
inferred← citeshttps://doi.org/10.1021/acs.jproteome.2c00064openalex-snapshot
Subchronic Graphene Exposure Reshapes Skin Cell Metabolism
inferred← citeshttps://doi.org/10.1038/ajg.2013.11openalex-snapshot
Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension
inferred← citeshttps://doi.org/10.1038/ejcn.2017.43openalex-snapshot
Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample
inferred← citeshttps://doi.org/10.1038/nrgastro.2015.114openalex-snapshot
The promise of metabolic phenotyping in gastroenterology and hepatology
inferred← citeshttps://doi.org/10.1038/s41388-023-02902-4openalex-snapshot
RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1/ACSL4
inferred← citeshttps://doi.org/10.1038/s41467-023-44364-yopenalex-snapshot
Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use
inferred← citeshttps://doi.org/10.1038/s41575-021-00502-9openalex-snapshot
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
inferred← citeshttps://doi.org/10.1038/s41598-017-03244-4openalex-snapshot
REG3β modifies cell tumor function by impairing extracellular vesicle uptake
inferred← citeshttps://doi.org/10.1038/s41598-017-10807-yopenalex-snapshot
A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients
inferred← citeshttps://doi.org/10.1038/s41598-017-14974-wopenalex-snapshot
Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors
inferred← citeshttps://doi.org/10.1038/s41598-018-32919-9openalex-snapshot
Atorvastatin provides a new lipidome improving early regeneration after partial hepatectomy in osteopontin deficient mice
inferred← citeshttps://doi.org/10.1038/s41598-019-53761-7openalex-snapshot
Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy
inferred← citeshttps://doi.org/10.1038/s41598-020-66458-zopenalex-snapshot
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1038/s41598-024-73406-8openalex-snapshot
The impact of steatotic liver disease on coronary artery disease through changes in the plasma lipidome
inferred← citeshttps://doi.org/10.1038/srep46735openalex-snapshot
Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida
inferred← citeshttps://doi.org/10.1042/bcj20240445openalex-snapshot
Loss of peroxiredoxin 6 alters lipid composition and distribution resulting in increased sensitivity to ferroptosis
inferred← citeshttps://doi.org/10.1042/bst20140138openalex-snapshot
Deciphering non-alcoholic fatty liver disease through metabolomics
inferred← citeshttps://doi.org/10.1053/j.gastro.2013.11.001openalex-snapshot
Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver Disease
inferred← citeshttps://doi.org/10.1053/j.gastro.2017.01.015openalex-snapshot
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1053/j.gastro.2020.05.056openalex-snapshot
Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122
inferred← citeshttps://doi.org/10.1053/j.gastro.2021.07.025openalex-snapshot
TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial
inferred← citeshttps://doi.org/10.1055/s-0039-1685519openalex-snapshot
Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice
inferred← citeshttps://doi.org/10.1080/15592294.2018.1514239openalex-snapshot
Histone variant macroH2A1 rewires carbohydrate and lipid metabolism of hepatocellular carcinoma cells towards cancer stem cells
inferred← citeshttps://doi.org/10.1080/20013078.2018.1470442openalex-snapshot
Metabolic alterations in urine extracellular vesicles are associated to prostate cancer pathogenesis and progression
inferred← citeshttps://doi.org/10.1080/20013078.2019.1575678openalex-snapshot
Differences in the metabolite composition and mechanical properties of extracellular vesicles secreted by hepatic cellular models
inferred← citeshttps://doi.org/10.1080/23808993.2019.1685379openalex-snapshot
Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1083/jcb.201503019openalex-snapshot
Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves
inferred← citeshttps://doi.org/10.1093/schbul/sbaa087openalex-snapshot
Association Between Circulating Lipids and Future Weight Gain in Individuals With an At-Risk Mental State and in First-Episode Psychosis
inferred← citeshttps://doi.org/10.1096/fj.201801551ropenalex-snapshot
Maternal prebiotic supplementation reduces fatty liver development in offspring through altered microbial and metabolomic profiles in rats
inferred← citeshttps://doi.org/10.1096/fj.202002620rropenalex-snapshot
Relaxin has beneficial effects on liver lipidome and metabolic enzymes
inferred← citeshttps://doi.org/10.1097/cm9.0000000000002027openalex-snapshot
Non-invasive tests of non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1097/hep.0000000000000316openalex-snapshot
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
inferred← citeshttps://doi.org/10.1097/ijg.0000000000000603openalex-snapshot
Changes in the Lipidomic Profile of Aqueous Humor in Open-Angle Glaucoma
inferred← citeshttps://doi.org/10.1097/mcg.0000000000002079openalex-snapshot
Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1097/md.0000000000016717openalex-snapshot
Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury
inferred← citeshttps://doi.org/10.1097/mpg.0000000000002875openalex-snapshot
Lipidomics in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1097/qad.0000000000004538openalex-snapshot
Semaglutide improves markers of cardiovascular risk in people with HIV
inferred← citeshttps://doi.org/10.1097/txd.0000000000001227openalex-snapshot
Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
inferred← citeshttps://doi.org/10.1101/2021.10.01.462722openalex-snapshot
Synthetic glabridin derivatives mitigate steatohepatitis in a diet-induced biopsy-confirmed non-alcoholic steatosis hepatitis mouse model through paraoxonase-2
inferred← citeshttps://doi.org/10.1111/aos.13374openalex-snapshot
Changes in lipidomic profile of aqueous humour in Fuchs endothelial dystrophy
inferred← citeshttps://doi.org/10.1111/apt.14674openalex-snapshot
Randomised clinical trial: a leucine‐metformin‐sildenafil combination ( NS ‐0200) vs placebo in patients with non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/apt.15606openalex-snapshot
Plasma metabolic alterations in patients with severe obesity and non‐alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1111/apt.16066openalex-snapshot
Circulating lipidomic alterations in obese and non‐obese subjects with non‐alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1111/dom.13285openalex-snapshot
Use of a metabolomic approach to non‐invasively diagnose non‐alcoholic fatty liver disease in patients with type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1111/eci.13695openalex-snapshot
Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non‐alcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1111/jgh.13335openalex-snapshot
Oxidized low‐density lipoprotein antibodies/high‐density lipoprotein cholesterol ratio is linked to advanced non‐alcoholic fatty liver disease lean patients
inferred← citeshttps://doi.org/10.1111/joim.13330openalex-snapshot
Technological readiness and implementation of genomic‐driven precision medicine for complex diseases
inferred← citeshttps://doi.org/10.1111/liv.12972openalex-snapshot
Metabolomics as a diagnostic tool for idiopathic non‐cirrhotic portal hypertension
inferred← citeshttps://doi.org/10.1111/liv.14042openalex-snapshot
Metabolomics discloses potential biomarkers to predict the acute HVPG response to propranolol in patients with cirrhosis
inferred← citeshttps://doi.org/10.1111/obr.12765openalex-snapshot
Adipose may actively delay progression of NAFLD by releasing tumor‐suppressing, anti‐fibrotic miR ‐122 into circulation
inferred← citeshttps://doi.org/10.1128/spectrum.05230-22openalex-snapshot
Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children
inferred← citeshttps://doi.org/10.11320/ningendockitn.5.1_3openalex-snapshot
“AminoIndex Technology” for Lifestyle-related Disease Risk Screening
inferred← citeshttps://doi.org/10.1136/gutjnl-2018-317584openalex-snapshot
Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1152/physrev.00008.2023openalex-snapshot
Ceramides are fuel gauges on the drive to cardiometabolic disease
inferred← citeshttps://doi.org/10.1155/2014/757929openalex-snapshot
Biomarkers in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1159/000538765openalex-snapshot
Metabolic Dysfunction-Associated Steatotic Liver Disease in Severe Obesity and Concordance between Invasive (Biopsy) and Noninvasive (OWLiver ® ) Diagnoses
inferred← citeshttps://doi.org/10.1172/jci189953openalex-snapshot
Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD
inferred← citeshttps://doi.org/10.1177/1535370215579161openalex-snapshot
Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine
inferred← citeshttps://doi.org/10.1177/1756284820923904openalex-snapshot
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis
inferred← citeshttps://doi.org/10.1186/s12916-015-0462-9openalex-snapshot
Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
inferred← citeshttps://doi.org/10.1186/s12944-021-01526-5openalex-snapshot
Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico
inferred← citeshttps://doi.org/10.1186/s12986-017-0213-3openalex-snapshot
Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
inferred← citeshttps://doi.org/10.1186/s13020-019-0251-zopenalex-snapshot
Metabolomics combined with network pharmacology exploration reveals the modulatory properties of Astragali Radix extract in the treatment of liver fibrosis
inferred← citeshttps://doi.org/10.1186/s13063-022-06608-yopenalex-snapshot
Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial “The EXER-COVID Crossover Study”
inferred← citeshttps://doi.org/10.1194/jlr.m078980openalex-snapshot
Osteopontin regulates the cross-talk between phosphatidylcholine and cholesterol metabolism in mouse liver
inferred← citeshttps://doi.org/10.1194/jlr.ra120000888openalex-snapshot
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
inferred← citeshttps://doi.org/10.1210/clinem/dgag018openalex-snapshot
Weight loss reduces intermuscular adipose tissue and liver fat compared to exercise: implications for muscle quality and metabolic health
inferred← citeshttps://doi.org/10.1210/jc.2014-4528openalex-snapshot
Age-Related Lipid Metabolic Signature in Human LMNA -Lipodystrophic Stem Cell-Derived Adipocytes
inferred← citeshttps://doi.org/10.1210/jc.2018-00999openalex-snapshot
Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes
inferred← citeshttps://doi.org/10.1212/nxi.0000000000000321openalex-snapshot
Metabolomic signatures associated with disease severity in multiple sclerosis
inferred← citeshttps://doi.org/10.12688/wellcomeopenres.14974.1openalex-snapshot
Metabolic profiling of adolescent non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.12688/wellcomeopenres.14974.2openalex-snapshot
Metabolic profiling of adolescent non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1371/journal.pone.0272623openalex-snapshot
Differential progression of unhealthy diet-induced hepatocellular carcinoma in obese and non-obese mice
inferred← citeshttps://doi.org/10.1371/journal.pone.0318557openalex-snapshot
Untargeted lipidomic analysis of metabolic dysfunction-associated steatohepatitis in women with morbid obesity
inferred← citeshttps://doi.org/10.1515/almed-2020-0062openalex-snapshot
Valoración bioquímica en la enfermedad hepática grasa asociada a la disfunción metabólica
inferred← citeshttps://doi.org/10.1515/almed-2021-0009openalex-snapshot
Biochemical assessment of metabolic associated fatty liver disease
inferred← citeshttps://doi.org/10.1515/cclm-2022-1105openalex-snapshot
Clinical lipidomics in the era of the big data
inferred← citeshttps://doi.org/10.15372/ssmj20180615openalex-snapshot
PROSPECTS FOR THE USE OF NATURAL ALKYL-GLYCEROLS IN TARGETED THERAPY OF BRONCHIAL ASTHMA ASSOCIATED WITH OBESITY (REVIEW)
inferred← citeshttps://doi.org/10.20517/2394-4722.2019.17openalex-snapshot
Circulating microRNAs and liquid biopsy: murine xenograft models for technical validation of clinical protocols
inferred← citeshttps://doi.org/10.21203/rs.3.rs-4653166/v1openalex-snapshot
Untargeted Lipidomics Analysis in Metabolic Dysfunction-Associated Steatohepatitis Associated with Morbid Obesity
inferred← citeshttps://doi.org/10.2217/clp.14.18openalex-snapshot
Regard Lipidomics in human nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.23860/diss-pfohl-marisa-2019openalex-snapshot
AN ‘OMICS APPROACH TO DIET & STRUCTURE IMPACT ON PERFLUOROALKYL SUBSTANCE INDUCED LIVER DISEASE
inferred← citeshttps://doi.org/10.26481/dis.20210428pvopenalex-snapshot
Non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3350/cmh.2021.0127openalex-snapshot
Recent advances in nonalcoholic fatty liver disease metabolomics
inferred← citeshttps://doi.org/10.3389/fcell.2026.1765945openalex-snapshot
Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma
inferred← citeshttps://doi.org/10.3389/fendo.2021.665987openalex-snapshot
Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.3389/fmed.2021.683250openalex-snapshot
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
inferred← citeshttps://doi.org/10.3389/fmed.2021.774079openalex-snapshot
MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
inferred← citeshttps://doi.org/10.3389/fmed.2026.1779292openalex-snapshot
MAST versus FAST for active fibrotic MASH: a meta-analysis supporting risk-stratified diagnostic pathways
inferred← citeshttps://doi.org/10.3389/fnut.2022.809865openalex-snapshot
Quality More Than Quantity: The Use of Carbohydrates in High-Fat Diets to Tackle Obesity in Growing Rats
inferred← citeshttps://doi.org/10.3389/fnut.2022.992682openalex-snapshot
Intake of slow-digesting carbohydrates is related to changes in the microbiome and its functional pathways in growing rats with obesity induced by diet
inferred← citeshttps://doi.org/10.3389/fphar.2022.827033openalex-snapshot
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
inferred← citeshttps://doi.org/10.3390/antiox11010086openalex-snapshot
Cell Models and Omics Techniques for the Study of Nonalcoholic Fatty Liver Disease: Focusing on Stem Cell-Derived Cell Models
inferred← citeshttps://doi.org/10.3390/antiox12051132openalex-snapshot
Plasma Lipidomics Profiles Highlight the Associations of the Dual Antioxidant/Pro-oxidant Molecules Sphingomyelin and Phosphatidylcholine with Subclinical Atherosclerosis in Patients with Type 1 Diabetes
inferred← citeshttps://doi.org/10.3390/biomedicines11020337openalex-snapshot
Impaired Function of Solute Carrier Family 19 Leads to Low Folate Levels and Lipid Droplet Accumulation in Hepatocytes
inferred← citeshttps://doi.org/10.3390/cancers10090300openalex-snapshot
Targeted UPLC-MS Metabolic Analysis of Human Faeces Reveals Novel Low-Invasive Candidate Markers for Colorectal Cancer
inferred← citeshttps://doi.org/10.3390/cancers10110447openalex-snapshot
Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers12061419openalex-snapshot
Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.3390/cancers12061433openalex-snapshot
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
inferred← citeshttps://doi.org/10.3390/cancers17142339openalex-snapshot
Metabolic Signature in Combination with Fecal Immunochemical Test as a Non-Invasive Tool for Advanced Colorectal Neoplasia Diagnosis
inferred← citeshttps://doi.org/10.3390/ijms21239043openalex-snapshot
Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis
inferred← citeshttps://doi.org/10.3390/ijms24054941openalex-snapshot
Classification of Common Food Lipid Sources Regarding Healthiness Using Advanced Lipidomics: A Four-Arm Crossover Study
inferred← citeshttps://doi.org/10.3390/ijms24108509openalex-snapshot
Twelve Weeks of High-Intensity Interval Training Alters Adipose Tissue Gene Expression but Not Oxylipin Levels in People with Non-Alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.3390/ijms241612717openalex-snapshot
Plasma Lipids Profile in the Prediction of Non-Alcoholic Steatohepatitis in Adults: A Case-Control Study
inferred← citeshttps://doi.org/10.3390/jcm9051246openalex-snapshot
Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
inferred← citeshttps://doi.org/10.3390/livers2040020openalex-snapshot
One Carbon Metabolism and S-Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes
inferred← citeshttps://doi.org/10.3390/metabo10040168openalex-snapshot
Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach
inferred← citeshttps://doi.org/10.3390/metabo12090881openalex-snapshot
Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population
inferred← citeshttps://doi.org/10.3390/metabo8010017openalex-snapshot
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives
inferred← citeshttps://doi.org/10.3390/nu11040844openalex-snapshot
A Slow-Digesting Carbohydrate Diet during Rat Pregnancy Protects Offspring from Non-Alcoholic Fatty Liver Disease Risk through the Modulation of the Carbohydrate-Response Element and Sterol Regulatory Element Binding Proteins
inferred← citeshttps://doi.org/10.3390/nu15163637openalex-snapshot
Dietary ω3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study
inferred← citeshttps://doi.org/10.35376/10324/16788openalex-snapshot
Factores analíticos, antropométricos y dietéticos asociados al desarrollo de Esteatohepatitis y Fibrosis en pacientes con enfermedad por hígado graso no alcohólica
showing the first 200 of 221 · page through all 221
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.